Rising Prevalence Of Peripheral Artery Diseases Expected To Drive Growth In Peripheral Artery Disease Market: Key Factor Driving The Growth In The Peripheral Artery Disease Market

The Peripheral Artery Disease Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Expected Peripheral Artery Disease Market Size During the Forecast Period?
The market size for peripheral artery disease has seen robust growth in the past few years. The market is projected to increase from $4.31 billion in 2024 to $4.63 billion in 2025, growing at a compound annual growth rate (CAGR) of 7.5%. The growth during the previous period is a result of the rising prevalence of risk factors, an aging population trend, advancements in clinical research and data-backed medicine, expanded awareness and screening programs, along with governmental initiatives in healthcare.

Predictions for the peripheral artery disease market indicate a robust growth in the coming years, with the market size expected to reach $6.23 billion by 2029, growing at a compound annual growth rate (CAGR) of 7.7%. The surge during the forecast period can be linked to the emphasis on patient-centred healthcare, advancements in minimally invasive surgery techniques, digitization of health and remote patient monitoring, regenerative medical therapies, and specialised pharmaceutical treatments. Key future trends include initiatives for health equality, the adaptation of wearable technology, broadening of home-bound therapy sessions, feedback from patients (pros), and the transition to outpatient healthcare environments.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12068

What Are the High-Growth Segments in the Peripheral Artery Disease Market?
The peripheral artery disease market covered in this report is segmented -

1) By Type: Peripheral Angioplasty Balloons, Peripheral Stents, Peripheral Catheters, Inferior Vena Cava (IVC) Filters, Plaque Modification Devices, Hemodynamic Flow Alteration Devices, Peripheral Accessories
2) By Drugs: Lipid-Lowering Drugs, Blood Pressure Lowering Drugs, Glucose Regulating Drugs, Blood Clot Preventing Drugs, Inotropes, Thrombolytics Agents, Anti-Inflammatory Agents
3) By Route of Administration: Oral, Parenteral, Other Routes of Administration
4) By End Users: Hospitals, Specialty Clinics, Other End Users

Subsegments:
1) By Peripheral Angioplasty Balloons: Drug-Eluting Balloons, Non-Drug-Eluting Balloons, Scoring Balloons, Cutting Balloons
2) By Peripheral Stents: Drug-Eluting Stents, Bare Metal Stents, Covered Stents
3) By Peripheral Catheters: Sheath Introducers, Guidewires, Diagnostic Catheters, Delivery Catheters
4) By Inferior Vena Cava (IVC) Filters: Retrievable IVC Filters, Permanent IVC Filters
5) By Plaque Modification Devices: Atherectomy Devices, Laser Atherectomy Devices, Rotational Atherectomy Devices
6) By Hemodynamic Flow Alteration Devices: Flow Diversion Devices, Flow Restriction Devices
7) By Peripheral Accessories: Diagnostic Imaging Accessories, Accessory Kits for Interventional Procedures, Support Devices

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12068&type=smp

What Key Drivers Are Expected to Influence Future Peripheral Artery Disease Market Growth?
The growth of the peripheral artery disease market is likely to be fueled by the increasing prevalence of peripheral artery diseases. Referring to the blockage or narrowing of arteries beyond the heart, usually in the legs, peripheral artery diseases result in diminished blood flow and possible complications. Treating peripheral artery disease aids in reducing its symptoms, improving mobility, and decreasing the likelihood of severe complications, consequently enhancing the patient's quality of life. For instance, the American Heart Association, a nonprofit organization based in the United States, estimated in June 2023 that this condition affects between 7 to 12 million individuals in the United States and approximately 200 million people worldwide. Hence, the increasing incidence of peripheral artery diseases is propelling the growth of the peripheral artery disease market.

Which Companies Hold the Largest Share Across Different Peripheral Artery Disease Market Segments?
Major companies operating in the peripheral artery disease market include Cardinal Health Inc., Vascular Solutions Inc., Bayer AG, Abbott Laboratories, Medtronic plc., Koninklijke Philips N.V. (Royal Philips), B. Braun Melsungen AG., Terumo Corporation, Edwards Lifesciences, Becton Dickinson and Company (BD), Boston Scientific Corporation Incorporated, Cook Group Incorporated, Merit Medical Systems Inc., NuVasive Inc., Arjo AB, Penumbra Inc., BIOTRONIK SE and Co. KG, AngioDynamics Inc., Shockwave Medical Inc., Cardiovascular Systems Inc., Endologix LLC., LeMaitre Vascular Inc., Silk Road Medical Inc., WL Gore and Associates Inc., MicroPort Scientific Corporation, Bard Peripheral Vascular Inc., Avinger Inc.

What Trends Are Driving Growth in The Peripheral Artery Disease Market?
The peripheral artery disease market is seeing a surge in the adoption of state-of-the-art technological solutions as a key trend. Leading companies in this market are leveraging advanced surgical interventions to maintain their market standing. For example, Genesis MedTech Group, a medical device firm based in Singapore, announced the launch of a chocolate touch paclitaxel DCB catheter in November 2022. This percutaneous transluminal angioplasty (PTA) catheter has been developed to treat patients suffering from superficial femoral artery and popliteal artery disease. The Chocolate Touch, the only balloon catheter, fuses next-gen angioplasty platform with a drug delivery system targeting peripheral artery disease treatment. Its unique design includes pillow-like formations coated with a therapeutic agent that unfolds in minuscule sections, offering an alternative to traditional drug-coated balloon angioplasty for peripheral artery disease patients. The balloon area expands, resulting in more efficient drug delivery to the vessel wall and foregoing the need for permanent implants.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/peripheral-artery-disease-global-market-report

What Are the Emerging Geographies for The Peripheral Artery Disease Market Growth?
North America was the largest region in the peripheral artery disease market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the peripheral artery disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Peripheral Artery Disease Market?
2. What is the CAGR expected in the Peripheral Artery Disease Market?
3. What Are the Key Innovations Transforming the Peripheral Artery Disease Industry?
4. Which Region Is Leading the Peripheral Artery Disease Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.